These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19454041)

  • 1. Outcome based subgroup analysis: a neglected concern.
    Hirji KF; Fagerland MW
    Trials; 2009 May; 10():33. PubMed ID: 19454041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges and solutions to pre- and post-randomization subgroup analyses.
    Desai M; Pieper KS; Mahaffey K
    Curr Cardiol Rep; 2014; 16(10):531. PubMed ID: 25135344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
    Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G
    Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primer: the fallacy of subgroup analysis.
    Guillemin F
    Nat Clin Pract Rheumatol; 2007 Jul; 3(7):407-13. PubMed ID: 17599075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Level of evidence for promising subgroup findings: The case of trends and multiple subgroups.
    Tanniou J; Smid SC; van der Tweel I; Teerenstra S; Roes KCB
    Stat Med; 2019 Jun; 38(14):2561-2572. PubMed ID: 30868624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Issues related to subgroup analysis in clinical trials.
    Cui L; Hung HM; Wang SJ; Tsong Y
    J Biopharm Stat; 2002 Aug; 12(3):347-58. PubMed ID: 12448576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis.
    Hayward RA; Kent DM; Vijan S; Hofer TP
    BMC Med Res Methodol; 2006 Apr; 6():18. PubMed ID: 16613605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
    Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
    Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothesis testing in clinical trials.
    Green SB
    Hematol Oncol Clin North Am; 2000 Aug; 14(4):785-95, vii-viii. PubMed ID: 10949773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction effects and subgroup analyses in clinical trials: more than meets the eye?
    Sevdalis N; Jacklin R
    J Eval Clin Pract; 2008 Oct; 14(5):919-22. PubMed ID: 18373582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inference on subgroups identified based on a heterogeneous treatment effect in a post hoc analysis of a clinical trial.
    Zhao B; Ivanova A; Fine J
    Clin Trials; 2023 Aug; 20(4):370-379. PubMed ID: 37170632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes.
    Tanniou J; van der Tweel I; Teerenstra S; Roes KC
    BMC Med Res Methodol; 2016 Feb; 16():20. PubMed ID: 26891992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical properties of randomization in clinical trials.
    Lachin JM
    Control Clin Trials; 1988 Dec; 9(4):289-311. PubMed ID: 3060315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post hoc subgroup analysis and the truth of a clinical trial.
    Adams KF
    Am Heart J; 1998 Nov; 136(5):753-8. PubMed ID: 9812066
    [No Abstract]   [Full Text] [Related]  

  • 16. General guidance on exploratory and confirmatory subgroup analysis in late-stage clinical trials.
    Dmitrienko A; Muysers C; Fritsch A; Lipkovich I
    J Biopharm Stat; 2016; 26(1):71-98. PubMed ID: 26366479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A flexible strategy for testing subgroups and overall population.
    Alosh M; Huque MF
    Stat Med; 2009 Jan; 28(1):3-23. PubMed ID: 18985704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post hoc analyses: after the facts.
    Srinivas TR; Ho B; Kang J; Kaplan B
    Transplantation; 2015 Jan; 99(1):17-20. PubMed ID: 25525920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and analytic concepts for periodontal clinical trials.
    Imrey PB; Chilton NW
    J Periodontol; 1992 Dec; 63(12 Suppl):1124-40. PubMed ID: 1479532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment evaluation for a data-driven subgroup in adaptive enrichment designs of clinical trials.
    Zhang Z; Chen R; Soon G; Zhang H
    Stat Med; 2018 Jan; 37(1):1-11. PubMed ID: 28948633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.